BOTHELL, WA – November 9, 2009 – SonoSite, Inc. (Nasdaq:SONO), the world leader and specialist in hand-carried ultrasound for point-of-care medicine, today announced the expansion of the SonoAccess™ iPhone® application to include musculoskeletal specialties. SonoAccess is the first iPhone application to provide physicians with a comprehensive multimedia database of ultrasound resource materials.

Dedicated to providing innovative educational tools to musculoskeletal physicians, the SonoAccess app is customized for rheumatologists, orthopedic surgeons, physiatrists and sports medicine physicians. Partnering with leading physicians and educators within the ultrasound community, SonoSite has created a comprehensive library of scanning technique videos with case studies and an expansive image gallery to meet the needs of musculoskeletal physicians.

“As technology advancements emerge all around us and physicians become increasingly ‘tech’ savvy, SonoSite is staying ahead of the curve with the SonoAccess application,” said Steven Sampson, Doctor of Osteopathy, Orthohealing Center, Los Angeles. “SonoAccess is an excellent point of reference and is a quick and easy to use application that is accelerating the learning process for novice ultrasound users by changing the way physicians obtain information. In addition to formal training, SonoAccess can be used as a personal coaching tool, with tips and video demonstrations for medical treatments. Literally, SonoSite is placing a free resource for ultrasound guidance at a physician’s fingertips.”

Clinicians worldwide are benefitting from SonoAccess. For more information about the application, visit www.sonoaccess.com.

About SonoSite
SonoSite, Inc. (www.sonosite.com) is the innovator and world leader in hand-carried ultrasound. Headquartered near Seattle, the company is represented by ten subsidiaries and a global distribution network in over 100 countries. SonoSite’s small, lightweight systems are expanding the use of ultrasound across the clinical spectrum by cost-effectively bringing high performance ultrasound to the point of patient care.

iPhone is a trademark of Apple, Inc., registered in the US and other countries.

BOTHELL, WA – October 27, 2009 – SonoSite, Inc. (Nasdaq:SONO), the world leader and specialist in hand-carried ultrasound for the point-of-care, today reported financial results for the third quarter and nine months ended September 30, 2009.

REVENUE
Revenue in the third quarter of 2009 was $53.6 million, a decrease of 13% compared to the third quarter of 2008. For the nine months of 2009, revenue was $157.7 million, a decrease of 9% compared to the nine months of 2008.

Overall revenue included $3.0 million for the quarter and nine months just ended from the recently acquired CardioDynamics International Corporation (CDIC).

Excluding CDIC, revenue in the third quarter was $50.6 million, a decrease of 18% compared to the third quarter of 2008, and $154.7 million for the nine months just ended.

Foreign exchange had zero effect on third quarter revenue, but had a negative impact of $6.7 million or 4% for the nine months just ended.

OPERATING INCOME AND CASH FLOW
Overall, “reported” third quarter operating income was $2.3 million, including charges from CDIC of $3.1 million related to operating results as well as acquisition and integration.
Operating income in the third quarter excluding CDIC was $5.4 million, a 10.7% operating margin versus a $3.0 million or 5.6% operating margin in the second quarter 2009.

Cash Flow
Operating cash flow was $1.6 million for the quarter and $8.9 million for the nine months of 2009, as compared to $13.0 million and $18.0 million for the comparable periods of 2008. Operating cash flow reflects the decline in operating income and the $3.1 million impact of the CDIC acquisition.

Net income
For the third quarter of 2009, the Company recorded a net loss of $0.2 million or $0.01 per share, compared to a net income of $3.7 million or $0.21 per share in 2008. For the nine months of 2009, net income was $1.0 million or $0.06 per share compared to $5.3 million or $0.30 per share, all of which include $3.1 million in charges related to the CDIC acquisition.

COMMENTARY
“While revenue remained sluggish, gross margins and expense management improved, resulting in a better than forecasted operating margins of 10.7% in our core businesses, excluding CDIC,” said Kevin M. Goodwin, SonoSite President and CEO. “The revenue environment remains tight, US revenue levels continued stabilizing and we experienced a few order delays in our international business. Importantly, pricing and expense management have continued to improve, resulting in steadily increasing operating margin performance.”

“We also recently concluded an agreement with General Electric to settle our patent disputes,” Mr. Goodwin stated. “As a part of the settlement, both companies agreed to invest in an important new education and clinical research foundation, which the companies will co-fund, and which will contribute to the long-term market adoption of best practices in point-of-care ultrasound.”

“Our 2009 outlook remains unchanged,” Mr. Goodwin said. “Going forward, we intend to continuously improve our operating margins and cash flow while preparing and positioning ourselves for the resumption of revenue growth. We have numerous growth initiatives in place, alongside a strengthening handle on pricing and expense control. We are targeting operating margins of 11 – 13% for 2010. These targets assume zero to low revenue growth rates. If we realize greater growth rates, our operating margins will be structured to improve further. These projections exclude $3.3 million of expected amortization for intangibles related to the CDIC acquisition.”

As of September 30, 2009, the company held $248 million in cash and investments and had outstanding senior convertible notes of $120 million. The Company used $16.2 million for the CDIC acquisition including re-payment of their debt.

2009 FINANCIAL OUTLOOK
The Company has updated its outlook to include the impact of the CDIC acquisition:

• revenues in the range of $225 – $230 million,
• gross margins are expected to be level with 2008, and
• operating income in the range of $10 – $11 million inclusive of negative $8 million in charges from the CDIC acquisition.

NON-GAAP MEASURES
This release includes a discussion of management measures that are non-GAAP. We believe it is useful for investors to understand the comparison of operating results in 2009 versus 2008 by eliminating the impact of the CDIC related charges using non-GAAP measures.

Conference Call Information
SonoSite will hold a conference call on October 27th at 1:30 pm PT/4:30 pm ET. The call will be broadcast live and can be accessed via http://www.sonosite.com/company/investors. A replay of the audio webcast will be available beginning October 27, 2009, 5:30 pm PT and will be available until November 10, 2009, 9:59 pm PT by dialing (719) 457-0820 or toll-free (888) 203-1112. The confirmation code 1942151 is required to access the replay. The call will also be archived on SonoSite’s website.

About SonoSite
SonoSite, Inc. (www.sonosite.com) is the innovator and world leader in hand-carried ultrasound. Headquartered near Seattle, the company is represented by ten subsidiaries and a global distribution network in over 100 countries. SonoSite’s small, lightweight systems are expanding the use of ultrasound across the clinical spectrum by cost-effectively bringing high performance ultrasound to the point of patient care.

Forward-looking Information and the Private Litigation Reform Act of 1995
Certain statements in this press release relating to our future financial position and operating results are “forward-looking statements” for the purposes of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on the opinions and estimates of our management at the time the statements are made and are subject to risks and uncertainties that could cause actual results to differ materially from those expected or implied by the forward-looking statements. These statements are not guaranties of future performance, are based on potentially inaccurate assumptions and are subject to known and unknown risks and uncertainties, including, without limitation, the risk that the acquisition of CardioDynamics will not yield the expected potential benefits, our ability to manufacture, market and sell our newest products, spending patterns in the hospital market, healthcare reform and the other factors contained in Item 1A. “Risk Factors” section of our most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission. We caution readers not to place undue reliance upon these forward-looking statements that speak only as to the date of this release. We undertake no obligation to publicly revise any forward-looking statements to reflect new information, events or circumstances after the date of this release or to reflect the occurrence of unanticipated events.

Download Selected Financial Information – Q3 2009 (PDF)

BOTHELL, WA – October 19, 2009 – SonoSite, Inc. (Nasdaq:SONO), the world leader and specialist in hand-carried ultrasound for the point-of-care, announced today that the company has resolved all pending patent litigation with General Electric Company (GE). This includes the lawsuit filed by GE in 2008 in the federal district court in Madison, Wisconsin (case no. 08-cv-298-bbc) to invalidate SonoSite’s US Patent No. 5,722,412 (the ‘412 patent) and a pending appeals in the Federal Circuit (case nos. 2008-1567, 2008-1568) of certain rulings in a patent infringement case filed by GE in the same Wisconsin court in 2007. The settlement also resolves a revocation action filed by GE in the Federal Patent Court in Germany relating to the ‘412 patent.

Under the terms of the settlement agreement, GE will make an up front payment to SonoSite of $21 million and pay an ongoing royalty on US sales and production of hand-carried ultrasound systems weighing less than ten pounds in exchange for a perpetual nontransferable worldwide license to the ‘412 patent family. SonoSite will receive these royalties until the ‘412 patent expires in 2016. The terms of the settlement provides for the dismissal of all pending legal actions between SonoSite and GE as well as a cross-license to the other party’s patents asserted in the lawsuits. The settlement agreement also includes a dispute resolution process, designed to avoid future litigation between the parties.

The companies have also agreed to form in a unique new foundation aimed at funding clinical research, education and training of best practices for point-of-care ultrasound. Other terms of the settlement are confidential.

Commenting on the settlement, SonoSite President and CEO, Kevin M. Goodwin said, “We are pleased with the outcome of this matter and have now fully resolved all of our pending litigation with GE. The agreement with GE is an important milestone in the development of point-of-care ultrasound. It not only affirms the value of our patents, but also will enable the expansion of our research program for point-of-care ultrasound in medicine. We believe that this resolution is positive for SonoSite, our customers, our partners and the overall ultrasound industry.”

About SonoSite
SonoSite, Inc. (www.sonosite.com) is the innovator and world leader in hand-carried ultrasound. Headquartered near Seattle, the company is represented by ten subsidiaries and a global distribution network in over 100 countries. SonoSite’s small, lightweight systems are expanding the use of ultrasound across the clinical spectrum by cost-effectively bringing high performance ultrasound to the point of patient care.

BOTHELL, WA – October 16, 2009 – SonoSite, Inc. (Nasdaq:SONO), the world leader and specialist in hand-carried ultrasound for the point-of-care, today announced that the new, 6 pound NanoMaxx™ ultrasound system will be making its debut, along with its workflow and mobile power solutions during the American Society of Anesthesiologists 2009 Annual Meeting. The conference is being held in New Orleans at the Ernest N. Morial Convention Center, October 18-20th.

The NanoMaxx Ultrasound Tool
Superior imaging in a small package, the NanoMaxx system is the latest ultrasound to join SonoSite’s product line for anesthesiologists. Engineered with the power and sophistication of SonoSite’s Turbo platform, the NanoMaxx system is reliable, durable and built to withstand the demands of the hospital environment. As with other SonoSite products, the NanoMaxx is backed by a 5-year standard warranty.

“The new NanoMaxx system is innovative and has a sleek, portable design,” said Ed Mariano, MD, Director of Regional Anesthesia and Assistant Clinical Professor, University of California San Diego. “With its touch-screen and simplified user-interface, anesthesiologists will be able to easily perform central line placement procedures, regional nerve blocks and visualize vessels without the need to manipulate the image. The NanoMaxx system truly is an impressive product and sets the standard for all portable ultrasound systems.”

• High resolution image quality – proprietary imaging algorithms enable anesthesiologists to easily place lines, perform regional nerve blocks and epidurals
• One button optimization and touch screen technology – for the ultimate in a streamlined user-interface
• Fluid resistant interface – easily clean and disinfect the system
• Space-saving solutions – mount the system on a stand or gas machine

SonoSite® Mobile Solutions
For true mobility to any point-of-care location around the hospital, SonoSite is now offering power solutions that are innovative, streamlined and can simply be integrated with SonoSite’s new ergonomic Universal Stands. The Universal Stands are configurable with the M-Turbo®, S Series™, NanoMaxx and MicroMaxx® product lines. With a new robust and lightweight architecture, the Universal Stands can be easily maneuvered through crowded hospital corridors and optimally positioned by the patient bedside or in other space-constrained areas.

• PowerPort – a cordless solution for charging the ultrasound system while docked in a Universal Stand.
• PowerPack – triples battery life up to 6 hours or more and can easily be installed on the column of the Universal Stand.

SonoSite® Workflow Solutions
A department based solution for managing patient data, SonoSite Workflow Solutions (SWS™) is an ultrasound image browser and reporting tool designed to enhance workflow by giving physicians the ability to store and manage ultrasound studies within the anesthesiology department.

Visit SonoSite at Booth # 1133 at ASA
Anesthesiologists can see a demonstration of the NanoMaxx system, workflow and mobile power solutions at ASA or can access a web-based demo of the NanoMaxx system by visiting www.sonosite.com/nanomaxx.

Also, Apple® iPhone® and iPod® mobile device users can access a video of the NanoMaxx system or browse through educational videos, case studies and images for anesthesiologists on SonoSite’s new SonoAccess™ application.

About SonoSite
SonoSite, Inc. (www.sonosite.com) is the innovator and world leader in hand-carried ultrasound. Headquartered near Seattle, the company is represented by ten subsidiaries and a global distribution network in over 100 countries. SonoSite’s small, lightweight systems are expanding the use of ultrasound across the clinical spectrum by cost-effectively bringing high performance ultrasound to the point of patient care.

iPhone and iPod are trademarks of Apple, Inc., registered in the US and other countries.

A replay of the audio webcast will be available beginning October 27, 2009, 5:30 pm PT and will be available until November 10, 2009, 9:59 pm PT by dialing (719) 457-0820 or toll-free (888) 203-1112. The confirmation code 1942151 is required to access the replay. The call will also be archived on SonoSite’s website.

About SonoSite
SonoSite, Inc. (www.sonosite.com) is the innovator and world leader in hand-carried ultrasound. Headquartered near Seattle, the company is represented by ten subsidiaries and a global distribution network in over 100 countries. SonoSite’s small, lightweight systems are expanding the use of ultrasound across the clinical spectrum by cost-effectively bringing high performance ultrasound to the point of patient care.

BOTHELL, WA – October 5, 2009 – SonoSite, Inc. (Nasdaq:SONO), the world leader and specialist in hand-carried ultrasound for the point-of-care, announced today that the company has received FDA 510(k) clearance for its new NanoMaxx™ ultrasound system and is commencing US customer deliveries. International deliveries began at the end of June.

Based on SonoSite’s 4th generation Turbo technology, the six pound NanoMaxx system is the latest addition to SonoSite’s suite of specialized products for point-of-care visualization in medicine. Complete with streamlined one button optimization technology, a touch screen user interface and SonoSite’s industry-leading 5-year warranty, the NanoMaxx system is ideal for both hospital and office markets and designed to provide healthcare professionals with improved patient safety practices, expanded workflow capabilities and exam room flexibility.

Among the first to take delivery of a system, the Queensland Ambulance Service in Australia, is integrating ultrasound into their rapid response vehicle. “Ultrasound is an essential tool for providing immediate diagnostics, improving patient safety and ultimately raising the standard of patient care,” said Stephen Rashford, MD, the department’s medical director. “With a hand-carried system, our department will be able to assess and diagnose patients at the scene of an accident, such as aggressively managing chest injuries, and for higher level trauma cases, pre-notify the hospital of a patient’s arrival to guarantee the availability of an operating room.”

One Button Control for Increased Efficiency

The new ultra portable and one button design of the NanoMaxx system makes high quality ultrasound available to a much broader range of clinicians. The system incorporates SonoSite’s advanced proprietary imaging algorithms, including SonoMB™ and SonoAdapt™ to deliver superior image quality in a lightweight, rugged form factor.

With a touch screen that responds easily to the tap of a finger, and one button optimization, clinicians can readily acquire high resolution images to increase clinical productivity at the point-of-care. A system boot-up time of less than 20 seconds and long battery life further enhance workflow when using the NanoMaxx system.

Reduce Length of Stay. Improve Patient Safety.

Designed to help hospitals meet the new standards of patient care, the NanoMaxx is the perfect diagnostic ultrasound for clinical assessment and procedural guidance at the hospital bedside and in the physician’s office. The ultimate tool for reducing patient safety risks and healthcare delivery costs, the use of bedside ultrasound is proven to increase the accuracy of interventional procedures and the use of ultrasound guidance is now recommended by two government-based agencies¹ and three US medical societies².

At introduction, the NanoMaxx tool is available with a complement of five transducers to support a wide range of examinations and procedures including thoracic assessment for pathology, vascular access, needle aspirations and injections, as well as abdominal, cardiac, nerve, OB/Gyn, musculoskeletal, small parts and vascular scanning. The clinical capabilities of the NanoMaxx will help eliminate the risk and cost of transporting patients to the imaging lab for many examinations and procedures.

Mount it. Carry it. Or Use it on a Stand.

The small footprint of the system, along with its space-saving solutions, enables seamless integration with a multitude of exam-room configurations. For convenience and flexibility, the system can be wall mounted, placed on an exam table with kickstand attached, or used from a highly maneuverable stand. Physicians can easily carry the NanoMaxx tool from room-to-room, to a satellite office, to the operating room or to a field site for immediate use.

Drop Tested at 3 Feet

The NanoMaxx system’s highly integrated architecture and ruggedized design, including the industry’s first elastomeric bumper for extra durability, plus magnesium outer shell, allows it to be used in the most demanding and austere environments. Proving its reliability, the NanoMaxx system and its transducers successfully passed SonoSite’s standard three foot durability drop test.

In addition, to further reduce the risk of infection, the NanoMaxx system’s fluid-resistant user interface makes the system easy to clean and disinfect, helping to address the growing concern over infection control in the medical community.

Affordable and Easily Accessible with Web-Based Purchasing Program

Affordably priced, the NanoMaxx system and its transducers include SonoSite’s industry-leading 5-year warranty, to provide the lowest cost of ownership in ultrasound.

Also, SonoSite’s One-to-One Purchase Program further extends the cost saving advantages of the NanoMaxx ultrasound tool by replacing or complementing the traditional on-site, pre-sale demonstration with a personal phone consultation and webcast demonstration provided by a professional clinical sales consultant. Visit the NanoMaxx ultrasound tool website to learn more about SonoSite’s newest system and to experience a personal, interactive product demo. In addition, Apple® iPhone® and iPod® mobile device users can view a video of the NanoMaxx system on SonoSite’s new SonoAccess™ application.

About SonoSite

SonoSite, Inc. (www.sonosite.com) is the innovator and world leader in hand-carried ultrasound. Headquartered near Seattle, the company is represented by ten subsidiaries and a global distribution network in over 100 countries. SonoSite’s small, lightweight systems are expanding the use of ultrasound across the clinical spectrum by cost-effectively bringing high performance ultrasound to the point of patient care. The company employs approximately 750 people worldwide.

¹ Agency for Health Care Research and Quality (AHRQ) report: Making Healthcare Safer: A Critical Analysis of Patient Safety Practices 2001. National Institute for Clinical Excellence (NICE) report: Guidance on the Use of Ultrasound Locating Devices for Placing Central Venous Catheters. 2002.

² The American Board of Internal Medicine. “Training and Procedural Requirements; Critical Care Medicine.” Critical Care Medicine Policies. 2009. The American Board of Internal Medicine. (certification/policies/imss/ccm.aspx#tpr). The American College of Chest Physicians. “Consensus Statement; La Societe de Reanimation de Langue Francaise Statement on Competence in Critical Care Ultrasonography.” 135 (2009): 1050-1060. The American College of Emergency Physicians. “Policy Statement; Emergency Ultrasound Guidelines.” 53 (2009): 550-70.

Forward-looking Information and the Private Litigation Reform Act of 1995
Certain statements in this press release relating to the market acceptance of our products, possible future sales relating to expected orders, and our future financial position and operating results are “forward-looking statements” for the purposes of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on the opinions and estimates of our management at the time the statements are made and are subject to risks and uncertainties that could cause actual results to differ materially from those expected or implied by the forward-looking statements. These statements are not guaranties of future performance and are subject to known and unknown risks and uncertainties and are based on potentially inaccurate assumptions. Factors that could affect the rate and extent of market acceptance of our products, the receipt of expected orders, and our financial performance include our ability to successfully manufacture, market and sell our ultrasound systems, our ability to accurately forecast customer demand for our products, our ability to manufacture and ship our systems in a timely manner to meet customer demand, variability in quarterly results caused by the timing of large project orders from governmental or international entities and the seasonality of hospital purchasing patterns, timely receipts of regulatory approvals to market and sell our products, regulatory and reimbursement changes in various national health care markets, constraints in government and public health spending, the ability of our distribution partners and other sales channels such as the physician office sales force to market and sell our products, the impact of patent litigation, our ability to execute our acquisition strategy, the effect of transactions and activities associated with our issuance of senior convertible debt in July 2007 on the market price of our common stock, and as well as other factors contained in the Item 1A. “Risk Factors” section of our most recent Annual Report on Form 10-K, as updated by our most recent quarterly reports filed on Form 10-Q filed with the Securities and Exchange Commission. We caution readers not to place undue reliance upon these forward-looking statements that speak only as to the date of this release. We undertake no obligation to publicly revise any forward-looking statements to reflect new information, events or circumstances after the date of this release or to reflect the occurrence of unanticipated events.

iPhone and iPod are trademarks of Apple, Inc., registered in the US and other countries.

SonoSite’s PowerPort allows cordless charging of the SonoSite system when it is mounted or docked in the Universal Stand. Parking the stand on the PowerPort eliminates the need to find an electrical outlet and provides a designated station for the stand and system. SonoSite’s PowerPack triples battery life and can keep a system charged for 6 hours or more allowing clinicians the flexibility needed to see more patients on a single charge. The PowerPack is easily installed on the column of SonoSite’s Universal Stand.

SonoSite also announced its new ergonomic Universal Stands for added versatility and increased mobility. Compatible with the M-Turbo®, S Series™, NanoMaxx™¹ and MicroMaxx® product lines, SonoSite’s Universal Stands are light, easy to customize with accessories, highly maneuverable in the hospital setting and easily positioned by the patient bedside or in other space-constrained areas.

Customer deliveries are expected to begin at the end of the fourth quarter 2009.

¹ Availability in the US pending FDA 510(k) clearance.

About SonoSite

SonoSite, Inc. (www.sonosite.com) is the innovator and world leader in hand-carried ultrasound. Headquartered near Seattle, the company is represented by ten subsidiaries and a global distribution network in over 100 countries. SonoSite’s small, lightweight systems are expanding the use of ultrasound across the clinical spectrum by cost-effectively bringing high performance ultrasound to the point of patient care.

Forward-looking Information and the Private Litigation Reform Act of 1995
Certain statements in this press release relating to the potential benefits of SonoSite’s future products and technology are “forward-looking statements” for the purposes of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on the opinions and estimates of our management at the time the statements are made and are subject to risks and uncertainties that could cause actual results to differ materially from those expected or implied by the forward-looking statements. These statements are not guaranties of future performance, are based on potentially inaccurate assumptions and are subject to known and unknown risks and uncertainties, including, without limitation, the risk that these products and technology will not yield the expected potential benefits, and the other factors contained in Item 1A. “Risk Factors” section of our most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission. We caution readers not to place undue reliance upon these forward-looking statements that speak only as to the date of this release. We undertake no obligation to publicly revise any forward-looking statements to reflect new information, events or circumstances after the date of this release or to reflect the occurrence of unanticipated events.

BOTHELL, WA–October 5, 2009–SonoSite, Inc. (Nasdaq:SONO), the world leader and specialist in hand-carried and point-of-care ultrasound, announced today the introduction of SonoSite® Workflow Solutions (SWS™), a suite of specialized tools designed to streamline exam management at the departmental level by giving physicians the ability to browse, manage and store ultrasound studies and generate reports suitable for billing and credentialing.

“SonoSite Workflow Solutions will be indispensible for any department performing quality assurance, and will save time for departments wanting control over their ultrasound studies,” said Dr. Alfredo Sabbaj, MD, MA, Assistant Professor Department of Emergency Medicine, Oregon Health and Science University in Portland. “With the SWS program I can review and archive studies, credential and generate reports all in one place rather than having to use multiple programs in sequence or go through another department’s software to do the same thing. Also for teaching hospitals, SWS allows residents to get feedback on their studies faster, and the more feedback they get the quicker they learn.”

Patient information and ultrasound images can be quickly transferred to the SWS program over either a wireless or Ethernet connection and automatically pre-populate patient information forms built into SWS. The SWS program will support any number of user accounts within a department and is capable of importing ultrasound studies from multiple SonoSite systems. Simplified system administration also provides flexibility for managing users and audit logging user activity. The software operates on both PC and Macintosh® platforms and is server based—accessed within the department’s firewall via laptop or desktop using the local area network (LAN) available to specific departments. For more information on SWS visit our website.

About SonoSite

SonoSite, Inc. (www.sonosite.com) is the innovator and world leader in hand-carried ultrasound. Headquartered near Seattle, the company is represented by ten subsidiaries and a global distribution network in over 100 countries. SonoSite’s small, lightweight systems are expanding the use of ultrasound across the clinical spectrum by cost-effectively bringing high performance ultrasound to the point of patient care.

Mac is a trademark of Apple, Inc., registered in the U.S. and other countries.

DICOM is the registered trademark of the National Electrical Manufacturers Association for its standards publications relating to digital communications of medical information.

“SonoSite hand-carried and mountable products have revolutionized patient safety, quality and cost of care in medicine by enabling simple and efficient ultrasound visualization at the point-of-care,” said Kevin M. Goodwin, SonoSite President and CEO. “We know and respect that time is critical for medical professionals, so we have streamlined our website’s navigation process. Users can access digital content quickly and efficiently. Health care consumers and other visitors to the website will also find relevant information about our company and how point-of-care ultrasound is improving patient safety, quality and cost in medical delivery.”

In the new website, SonoSite has greatly expanded the Healthcare Professions Section to enable medical professionals to explore information that is pertinent to their specialty. Each healthcare profession-specific section contains information about applicable SonoSite products, an overview of using ultrasound as a diagnostic tool, reimbursement, financial options, and an image gallery that depicts specialty-specific images captured with SonoSite ultrasound systems.

Because SonoSite is committed to building a long-term relationship with its customers, the Education Section of the company’s website is greatly expanded. By providing more learning opportunities, the new website ensures that clinicians can optimize the use of their SonoSite ultrasound systems and have a comprehensive range of learning activities and resources to meet their current and future educational needs. In addition, the website contains an abundant library of videos and images to help people optimize their scanning techniques and image interpretation skills.

A new Evidence Section now details how medical offices, hospitals, and healthcare clinics are benefiting from point-of-care ultrasound in their day-to-day practice. This section highlights how ultrasound reduces patient complications, increases procedure success rates, and reduces financial strain on medical facilities.

Visit www.sonosite.com and register for premium access. This free-of-charge registration enables a wide range of complimentary multimedia files and downloads available on the SonoSite website.

About SonoSite
SonoSite, Inc. (www.sonosite.com) is the innovator and world leader in hand-carried ultrasound. Headquartered near Seattle, the company is represented by ten subsidiaries and a global distribution network in over 100 countries. SonoSite’s small, lightweight systems are expanding the use of ultrasound across the clinical spectrum by cost-effectively bringing high performance ultrasound to the point of patient care. The company employs approximately 750 people worldwide.

Forward-looking Information and the Private Litigation Reform Act of 1995
Certain statements in this press release relating to the benefits of SonoSite’s current and future products and technology are “forward-looking statements” for the purposes of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on the opinions and estimates of our management at the time the statements are made and are subject to risks and uncertainties that could cause actual results to differ materially from those expected or implied by the forward-looking statements. These statements are not guaranties of future performance, are based on potentially inaccurate assumptions and are subject to known and unknown risks and uncertainties, including, without limitation, the risk that these products and technology will not yield the expected potential benefits, and the other factors contained in Item 1A. “Risk Factors” section of our most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission. We caution readers not to place undue reliance upon these forward-looking statements that speak only as to the date of this release. We undertake no obligation to publicly revise any forward-looking statements to reflect new information, events or circumstances after the date of this release or to reflect the occurrence of unanticipated events.

Mr. Goodwin’s presentation will be webcast live on September 23, 2009 at 8:30 am Eastern Time. An audio replay will be available for 30 days following and can be accessed via SonoSite’s website at http://www.sonosite.com/investorinformation/webcasts/.

About SonoSite
SonoSite, Inc. (www.sonosite.com) is the innovator and world leader in hand-carried ultrasound. Headquartered near Seattle, the company is represented by ten subsidiaries and a global distribution network in over 100 countries. SonoSite’s small, lightweight systems are expanding the use of ultrasound across the clinical spectrum by cost-effectively bringing high performance ultrasound to the point of patient care. The company employs approximately 750 people worldwide.